These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29188724)
1. Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology. Abdel-Rahman O Future Oncol; 2017 Dec; 13(30):2811-2821. PubMed ID: 29188724 [TBL] [Abstract][Full Text] [Related]
2. Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer. Abdel-Rahman O Future Oncol; 2017 Oct; 13(25):2277-2284. PubMed ID: 28976218 [TBL] [Abstract][Full Text] [Related]
3. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system. Abdel-Rahman O Clin Transl Oncol; 2018 May; 20(5):670-677. PubMed ID: 29022170 [TBL] [Abstract][Full Text] [Related]
4. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer. Abdel-Rahman O Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860 [TBL] [Abstract][Full Text] [Related]
5. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients. Abdel-Rahman O Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248 [TBL] [Abstract][Full Text] [Related]
6. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer. Abdel-Rahman O Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma. Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859 [TBL] [Abstract][Full Text] [Related]
8. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database. Komiya T; Chaaya G; Powell E Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190 [TBL] [Abstract][Full Text] [Related]
10. Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract. Abdel-Rahman O Clin Genitourin Cancer; 2018 Aug; 16(4):e859-e865. PubMed ID: 29534942 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts. Abdel-Rahman O Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376 [TBL] [Abstract][Full Text] [Related]
12. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma. Abdel-Rahman O Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839 [TBL] [Abstract][Full Text] [Related]
13. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting. Abdel-Rahman O Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003. Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648 [TBL] [Abstract][Full Text] [Related]
15. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival. Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247 [TBL] [Abstract][Full Text] [Related]
16. External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With N3 Disease. Shin JY; Yoon JK; Marwaha G Clin Lung Cancer; 2017 Nov; 18(6):e481-e489. PubMed ID: 28559200 [TBL] [Abstract][Full Text] [Related]
17. Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer. Oweira H; Schmidt J; Mehrabi A; Kulaksiz H; Schneider P; Schöb O; Giryes A; Abdel-Rahman O Future Oncol; 2018 Jan; 14(1):65-75. PubMed ID: 29235888 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database. Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045 [TBL] [Abstract][Full Text] [Related]
19. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer. Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy. Shi S; Xie H; Yin W; Zhang Y; Peng X; Yu F; Shemanski KA; Kim AW; Wang X J Surg Oncol; 2020 Jun; 121(8):1233-1240. PubMed ID: 32170977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]